We selected the APOE ε2, ε3, and ε4 alleles for evaluation because of the known and important contributions of these alleles to risk for other neurodegenerative diseases, specifically AD11,12 and age-related macular degeneration.49 The gene discussed is APOE; the disease is neurodegenerative disease.